Zurich Cantonal Bank
EWTX icon

Zurich Cantonal Bank’s Edgewise Therapeutics EWTX Stock Holding History

Zurich Cantonal Bank’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621K Buy
15,288
+549
+4% +$18.9K ﹤0.01% 1823
2026
Q1 		$464K Buy
14,739
+3,474
+31% +$100K ﹤0.01% 1869
2025
Q4 		$280K Buy
11,265
+4,402
+64% +$88.4K ﹤0.01% 2094
2025
Q3 		$111K Sell
6,863
-210
-3% -$2.98K ﹤0.01% 2365
2025
Q2 		$92.7K Hold
7,073
– – ﹤0.01% 2393
2025
Q1 		$156K Sell
7,073
-818
-10% -$21.5K ﹤0.01% 2224
2024
Q4 		$211K Sell
7,891
-270
-3% -$8.6K ﹤0.01% 2132
2024
Q3 		$218K Sell
8,161
-36
-0.4% -$716 ﹤0.01% 2063
2024
Q2 		$148K Sell
8,197
-18
-0.2% -$314 ﹤0.01% 2192
2024
Q1 		$150K Buy
+8,215
New +$131K ﹤0.01% 2210

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Zurich Cantonal Bank's EWTX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Edgewise Therapeutics (EWTX) stake by 3.7% in Q2 2026, buying an estimated $18.9K and bringing the position to 15,288 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Zurich Cantonal Bank first reported a position in EWTX in Q1 2024 and has held it in 10 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Zurich Cantonal Bank held 15,288 shares of Edgewise Therapeutics worth $621K as of Q2 2026.
  • Zurich Cantonal Bank bought 549 Edgewise Therapeutics shares in Q2 2026, an estimated $18.9K.
  • Edgewise Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1823 holding.
  • Zurich Cantonal Bank first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.